These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1979466)
1. The effect of pre-operative potassium iodide therapy on antibody production. Wilson R; McKillop JH; Thomson JA Acta Endocrinol (Copenh); 1990 Nov; 123(5):531-4. PubMed ID: 1979466 [TBL] [Abstract][Full Text] [Related]
2. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide. Wilson R; McKillop JH; Pearson C; Burnett AK; Gunn I; McNicol AM; Thomson JA Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232 [TBL] [Abstract][Full Text] [Related]
3. Carbimazole and the autoimmune response in Graves' disease. McGregor AM; Petersen MM; McLachlan SM; Rooke P; Smith BR; Hall R N Engl J Med; 1980 Aug; 303(6):302-7. PubMed ID: 6247656 [TBL] [Abstract][Full Text] [Related]
4. Evidence that thyroid-stimulating antibody is produced in the thyroid gland. Kendall-Taylor P; Knox AJ; Steel NR; Atkinson S Lancet; 1984 Mar; 1(8378):654-6. PubMed ID: 6142350 [TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy. Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117 [No Abstract] [Full Text] [Related]
6. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease. Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286 [TBL] [Abstract][Full Text] [Related]
7. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. Wilson R; McKillop JH; Pearson DW; Cuthbert GF; Thomson JA J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338 [TBL] [Abstract][Full Text] [Related]
8. Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. Feek CM; Sawers JS; Irvine WJ; Beckett GJ; Ratcliffe WA; Toft AD N Engl J Med; 1980 Apr; 302(16):883-5. PubMed ID: 6892650 [TBL] [Abstract][Full Text] [Related]
9. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro studies into the immunological changes following iodine 131 therapy for Graves' disease. Wilson R; McKillop JH; Jenkins C; Thomson JA Eur J Nucl Med; 1991; 18(4):265-8. PubMed ID: 1676969 [TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [TBL] [Abstract][Full Text] [Related]
13. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies. Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562 [TBL] [Abstract][Full Text] [Related]
15. Immunization with thyroglobulin induces Graves'-like disease in mice. Endo T; Kobayashi T J Endocrinol; 2009 Aug; 202(2):217-22. PubMed ID: 19491147 [TBL] [Abstract][Full Text] [Related]
17. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease. Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654 [TBL] [Abstract][Full Text] [Related]
18. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855 [TBL] [Abstract][Full Text] [Related]
19. Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay. Prentice MG; Rayman GA; Alaghband-Zadeh J; Wise PH J Endocrinol Invest; 1987 Oct; 10(5):483-9. PubMed ID: 2892877 [TBL] [Abstract][Full Text] [Related]
20. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease. Bossowski A; Stasiak-Barmuta A; Urban M Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]